Leif Gunnar Håkansson
Director Ejecutivo en CanImGuide Therapeutics AB .
Cargos activos de Leif Gunnar Håkansson
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Director/Miembro de la Junta | - | - |
| Director Ejecutivo | - | - | |
| Director Técnico/Científico/I+D | - | - | |
| Fundador | - | - |
Historial de carrera de Leif Gunnar Håkansson
Antiguos cargos conocidos de Leif Gunnar Håkansson.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
University of Linköping
 University of Linköping Other Consumer ServicesConsumer Services Linköping University Hospital provides healthcare services. | Corporate Officer/Principal | - | - |
| University of Lund | Corporate Officer/Principal | - | - |
Formación de Leif Gunnar Håkansson.
| University of Lund | Doctorate Degree |
Estadísticas
Internacional
| Suecia | 4 |
Operativa
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectorial
| Consumer Services | 3 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Health Technology |
